Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
Clinical trials are an essential part of the research and development (R&D) of new medicines and vaccines, bringing benefits to patients, the NHS and the economy.
Manufacturing and quality
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
This is the science of developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision-making.
Pharmacovigilance - drug safety
Drug safety (also known as pharmacovigilance), is the science of detection, assessment, understanding and prevention of side effects which allows us to understand more about the risks and benefits of a medicine.
Genomics in healthcare and research
The ABPI is committed to supporting the sector in bringing the latest advances in genomics technologies and treatments to patients, and genomics research to develop new drugs to treat disease.
The ABPI's People-centred Research Hub features a collection of member case studies that promote industry best practices in diversity and inclusion, patient and public involvement, and research transparency.